MoneyWorks4Me

Shilpa Medicare - Quaterly Results

11 Aug 2022 Evaluate
A decrease of about -42.34% in the sales to Rs. 608.34 millions was observed for the quarter ended June 2022. The sales stood at Rs. 1055.00 millions during the similar quarter previous year.The Net Profit of the company slipped to Rs. 38.54 millions from Rs. 88.49 millions, a decline of -56.45% on QoQ basis.Operating profit for the quarter ended June 2022 decreased to 171.30 millions as compared to 222.27 millions of corresponding quarter ended June 2021.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202206 202106 % Var 202206 202106 % Var 202203 202103 % Var
Sales 608.34 1055.00 -42.34 608.34 1055.00 -42.34 3569.52 2570.50 38.86
Other Income 126.28 93.98 34.37 126.28 93.98 34.37 408.62 322.46 26.72
PBIDT 171.30 222.27 -22.93 171.30 222.27 -22.93 625.49 656.16 -4.67
Interest 26.59 24.90 6.79 26.59 24.90 6.79 90.54 60.74 49.06
PBDT 144.71 197.37 -26.68 144.71 197.37 -26.68 623.04 1124.90 -44.61
Depreciation 104.21 71.10 46.57 104.21 71.10 46.57 348.18 222.81 56.27
PBT 40.50 126.27 -67.93 40.50 126.27 -67.93 274.86 902.09 -69.53
TAX 1.96 37.78 -94.81 1.96 37.78 -94.81 73.27 251.17 -70.83
Deferred Tax -5.14 4.88 -205.33 -5.14 4.88 -205.33 25.25 93.37 -72.96
PAT 38.54 88.49 -56.45 38.54 88.49 -56.45 201.59 650.92 -69.03
Equity 86.80 81.53 6.46 86.80 81.53 6.46 86.80 81.53 6.46
PBIDTM(%) 28.16 21.07 33.65 28.16 21.07 33.65 17.52 25.53 -31.35
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..